Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the intestinal fistula treatment market grown in recent years?
In previous years, the intestinal fistula treatment market has exhibited significant growth. The market is projected to expand from $25.27 billion in 2024 to $27.10 billion in 2025, representing a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this growth during the historic period could include the escalating frequency of gastrointestinal illnesses, an uptick in malnutrition cases, a growing elderly population, improvements in healthcare infrastructure, and an increase in healthcare expenditure.
How is the intestinal fistula treatment market size expected to evolve during the forecast period?
The market for intestinal fistula treatment is predicted to exhibit robust expansion in the forthcoming years, with an anticipated value of $35.35 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.9%. The expected proliferation within this period could be ascribed to factors such as the increasing adoption of telemedicine, a rise in disposable income, widespread cases of Crohn’s disease, an elderly population, and the amplified focus on tailoring medicine to individual needs. Significant trends predicted for this period include the use of artificial intelligence in diagnostic tools, developments in biologics, the introduction of 3D printing in medical applications, holistic care models, and the acceptance of wearable devices for health monitoring.
Get your intestinal fistula treatment market report here!
https://www.thebusinessresearchcompany.com/report/intestinal-fistula-treatment-global-market-report
Which key drivers are propelling the intestinal fistula treatment market’s growth?
The escalating incidences of gastrointestinal disorders are projected to fuel the expansion of the intestinal fistula treatment market. Conditions related to the digestive tract, characterized by symptoms like discomfort, bloating, constipation, or diarrhea, and necessitate medical examination and treatment, are classified as gastrointestinal disorders. Factors leading to a rise in gastrointestinal disorders include poor eating behaviors, anxiety, and psychological problems. The intestinal fistula treatment aids in the management of these disorders by sealing irregular intestinal links, preventing diseases, restoring intestinal function, and minimizing complications like undernutrition and blood poisoning. As per the data in September 2023 by the Centers for Disease Control and Prevention, a public health organization based in the US, around 14.8 million adults were affected by ulcers, forming 5.9% of the population and 35.4 million doctor consultations were recorded for digestive issues. Thus, the rising incidences of gastrointestinal disorders are a significant factor in the growth of the intestinal fistula treatment market. The enhancement of healthcare facilities also serves as a contributing factor for the elevation of the intestinal fistula treatment market. Healthcare facilities such as hospitals, clinics, and diagnostic centers that provide medical services and care are vibrant and progressing due to factors like the increased investment in healthcare infrastructure, a focus on patient-centric care, population growth, and aging. The intestinal fistula treatment supports the development of these facilities by improving patient outcomes, lessening complications, and effectively allocating resources. This leads to more efficient care delivery, fewer hospital stays, and better chronic conditions management, eventually resulting in a more beneficial and practical healthcare system. For example, as per the information provided by the American Health Care Association, a nonprofit organization based in the US, in May 2023, the number of hospitals reached 6,129, a 0.591% rise from the previous year when there were 6,093. Therefore, the evolvement of healthcare facilities is a crucial element propelling the growth of the intestinal fistula treatment market.
What are the market segments in the intestinal fistula treatment industry?
The intestinal fistula treatment market covered in this report is segmented –
1) By Treatment Type: Medications, Surgery, Nutritional Support, Other Treatment Type
2) By Route Of Administration: Oral, Rectal, Parenteral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-User
Subsegments:
1) By Medications: Antibiotics, Immunosuppressants, Antisecretory Agents, Pain Management Medications
2) By Surgery: Fistula Closure Surgery, Bowel Resection Surgery, Stoma Formation Surgery
3) By Nutritional Support: Parenteral Nutrition, Enteral Nutrition
4) By Other Treatment Type: Hyperbaric Oxygen Therapy, Endoscopic Fistula Closure
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21210&type=smp
Which leading companies are shaping the growth of the intestinal fistula treatment market?
Major companies operating in the intestinal fistula treatment market are Merck & Co. KGaA, Bristol-Myers Squibb, AstraZeneca plc, Pfizer Inc., Medtronic plc, Medtronic plc, Eli Lilly and Company, Moderna Inc., Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Cook Group Incorporated, Integra LifeSciences, Avante Health Solutions, Angiplast Pvt. Ltd., Angiplast Pvt. Ltd., Biolitec AG, Sklar Surgical Instruments, Livealth BioPharma, Surtex Instruments Limited, Advin Health Care
What emerging trends are influencing the growth of the intestinal fistula treatment market?
Prominent firms in the intestinal fistula treatment market are shifting their focus towards innovative therapeutic strategies, such as the mesenchymal stem cell (MSC) therapy, for managing persistent perianal fistulas. The MSC therapy involves the use of stem cells for fostering healing and regeneration of tissues, which is beneficial for patients with autoimmune diseases, osteoarthritis, and gastrointestinal issues. For instance, Ossium Health Inc., an American bioengineering firm, secured the Investigational New Drug (IND) application for their MSC product, OSSM-001, from the US-based Food and Drug Administration agency in March 2022. This crucial achievement paves the way for the company to initiate a multi-center Phase 1 clinical examination to assess the therapy’s safety and practicality. The trial will feature a double-blind, randomized, placebo-controlled method, focusing primarily on safety and fistula healing results.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21210
Which geographic areas are influencing the growth of the intestinal fistula treatment market?
North America was the largest region in the Intestinal Fistula Treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intestinal fistula treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Diabetic Foot Ulcer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-global-market-report
Diabetic Foot Ulcer Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report
Injection Molding Polyamide 6 Global Market Report 2025
https://thebusinessresearchcompany.com/report/virus-filtration-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
